Stephanie Krämer

1.5k total citations
38 papers, 1.2k citations indexed

About

Stephanie Krämer is a scholar working on Nephrology, Molecular Biology and Physiology. According to data from OpenAlex, Stephanie Krämer has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Nephrology, 9 papers in Molecular Biology and 9 papers in Physiology. Recurrent topics in Stephanie Krämer's work include Renal Diseases and Glomerulopathies (9 papers), Nitric Oxide and Endothelin Effects (7 papers) and Sphingolipid Metabolism and Signaling (5 papers). Stephanie Krämer is often cited by papers focused on Renal Diseases and Glomerulopathies (9 papers), Nitric Oxide and Endothelin Effects (7 papers) and Sphingolipid Metabolism and Signaling (5 papers). Stephanie Krämer collaborates with scholars based in Germany, United States and Japan. Stephanie Krämer's co-authors include Kim Bloomfield, Ulrike Grittner, Harm Peters, Gerhard Gmel, Hans‐H. Neumayer, Sebastian Martini, Hiroshi Kawachi, Lukasz Japtok, Susann Fayyaz and Burkhard Kleuser and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Stephanie Krämer

37 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephanie Krämer Germany 20 366 287 219 219 200 38 1.2k
Xinghui Li China 17 233 0.6× 248 0.9× 196 0.9× 92 0.4× 136 0.7× 43 968
Sonia Gaztambide Spain 24 305 0.8× 368 1.3× 99 0.5× 121 0.6× 149 0.7× 66 2.0k
Hsiang‐Chun Lee Taiwan 20 218 0.6× 92 0.3× 90 0.4× 80 0.4× 65 0.3× 79 1.2k
A. McElduff Australia 21 242 0.7× 258 0.9× 71 0.3× 127 0.6× 168 0.8× 45 1.8k
Rachel M. Freathy United Kingdom 24 392 1.1× 172 0.6× 33 0.2× 294 1.3× 44 0.2× 61 2.0k
Jer‐Chia Tsai Taiwan 18 359 1.0× 108 0.4× 421 1.9× 83 0.4× 40 0.2× 37 1.5k
Huifang Liang United States 17 262 0.7× 125 0.4× 51 0.2× 106 0.5× 167 0.8× 46 1.2k
Alice R Carter United Kingdom 10 206 0.6× 191 0.7× 27 0.1× 121 0.6× 73 0.4× 23 1.0k
Shahram Arsang‐Jang Iran 18 585 1.6× 141 0.5× 32 0.1× 77 0.4× 124 0.6× 145 1.4k
Hiroya Yamada Japan 21 729 2.0× 465 1.6× 21 0.1× 279 1.3× 107 0.5× 104 1.8k

Countries citing papers authored by Stephanie Krämer

Since Specialization
Citations

This map shows the geographic impact of Stephanie Krämer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Krämer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Krämer more than expected).

Fields of papers citing papers by Stephanie Krämer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Krämer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Krämer. The network helps show where Stephanie Krämer may publish in the future.

Co-authorship network of co-authors of Stephanie Krämer

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Krämer. A scholar is included among the top collaborators of Stephanie Krämer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Krämer. Stephanie Krämer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luca, Mónica Di, et al.. (2021). Future of the aging brain: Bridging the gap between research and policy. SHILAP Revista de lepidopterología. 1. 100002–100002. 5 indexed citations
2.
Nürnberg, Bernd, et al.. (2019). Renal Fibrosis, Immune Cell Infiltration and Changes of TRPC Channel Expression after Unilateral Ureteral Obstruction in Trpc6-/- Mice. Cellular Physiology and Biochemistry. 52(6). 1484–1502. 18 indexed citations
3.
Henkel, J, Korinna Jöhrens, Daniela Weber, et al.. (2017). Induction of Steatohepatitis (NASH) with Insulin Resistance in Wild-type B6 Mice by a Western-type Diet Containing Soybean Oil and Cholesterol. Molecular Medicine. 23(1). 70–82. 45 indexed citations
4.
Krämer, Stephanie, et al.. (2016). IL-17 Expression in the Time Course of Acute Anti-Thy1 Glomerulonephritis. PLoS ONE. 11(5). e0156480–e0156480. 12 indexed citations
5.
Japtok, Lukasz, et al.. (2015). Sphingosine 1-phosphate counteracts insulin signaling in pancreatic β-cells via the sphingosine 1-phosphate receptor subtype 2. The FASEB Journal. 29(8). 3357–3369. 43 indexed citations
6.
Krämer, Stephanie, et al.. (2015). Soluble guanylate cyclase stimulator BAY 41-8543 and female sex ameliorate uremic aortic remodeling in a rat model of mild uremia. Journal of Hypertension. 33(9). 1907–1921. 7 indexed citations
7.
Mannaa, Marwan, Stephanie Krämer, Michael Boschmann, & Maik Gollasch. (2013). mTOR and regulation of energy homeostasis in humans. Journal of Molecular Medicine. 91(10). 1167–1175. 20 indexed citations
8.
Fayyaz, Susann, J Henkel, Lukasz Japtok, et al.. (2013). Involvement of sphingosine 1-phosphate in palmitate-induced insulin resistance of hepatocytes via the S1P2 receptor subtype. Diabetologia. 57(2). 373–382. 76 indexed citations
9.
10.
Peters, Harm, Christian Kästner, Hartmut Kühn, et al.. (2009). Mechanisms of tubular volume retention in immune-mediated glomerulonephritis. Kidney International. 75(7). 699–710. 22 indexed citations
11.
Krämer, Stephanie, et al.. (2009). Stimulation of soluble guanylate cyclase accelerates renal recovery following relief of unilateral ureteral obstruction. BMC Pharmacology. 9(S1). 1 indexed citations
12.
Welker, Pia, Stephanie Krämer, David A. Groneberg, et al.. (2008). Increased mast cell number in human hypertensive nephropathy. American Journal of Physiology-Renal Physiology. 295(4). F1103–F1109. 32 indexed citations
13.
Krämer, Stephanie, E. M. Binder, Hiroshi Kawachi, et al.. (2007). Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat. American Journal of Physiology-Renal Physiology. 294(2). F440–F449. 59 indexed citations
14.
Krämer, Stephanie, Sebastian Martini, Torsten Böhler, et al.. (2005). Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril. American Journal of Physiology-Renal Physiology. 289(2). F359–F368. 37 indexed citations
15.
Krämer, Stephanie, Sebastian Martini, Susanne Kron, et al.. (2005). Enhancing cGMP in experimental progressive renal fibrosis: soluble guanylate cyclase stimulation vs. phosphodiesterase inhibition. American Journal of Physiology-Renal Physiology. 290(1). F167–F176. 53 indexed citations
16.
Bloomfield, Kim, Ulrike Grittner, & Stephanie Krämer. (2005). Developments in alcohol consumption in reunited Germany. Addiction. 100(12). 1770–1778. 11 indexed citations
17.
Peters, Harm, Lutz Liefeldt, Ralf Westenfeld, et al.. (2004). Platelet inhibition limits TGF-β overexpression and matrix expansion after induction of anti-thy1 glomerulonephritis. Kidney International. 65(6). 2238–2248. 18 indexed citations
19.
Peters, Harm, Sebastian Martini, Yingrui Wang, et al.. (2004). Selective lymphocyte inhibition by FTY720 slows the progressive course of chronic anti-thy 1 glomerulosclerosis. Kidney International. 66(4). 1434–1443. 41 indexed citations
20.
Peters, Harm, Sebastian Martini, Frank Schäper, et al.. (2003). NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis. Kidney International. 64(2). 509–518. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026